Award
Delivery Order #SPE2DR26FCSE6
Delivery Order for Nucala Auto-Injector from DMS Pharmaceutical Group
Buyer
Defense Logistics Agency
Award Amount
$3,863.68
Ceiling
$3,863.68
Awarded
March 11, 2026
Period of Performance
Mar 11, 2026 – Mar 12, 2026
Identifier
SPE2DR26FCSE6
NAICS
424210
This award is a delivery order contract issued to DMS Pharmaceutical Group Inc., a pharmaceutical distributor specializing in healthcare solutions. The contract procures a specific pharmaceutical product, the Nucala 100 mg/ml auto-injector, intended to support ongoing health initiatives requiring this medication. The award is significant as it ensures timely access to critical pharmaceutical products required by the agency, reinforcing continuous support for patient care. The scope includes the delivery of the specified Nucala auto-injector in a short performance window, demonstrating the agency's need for swift fulfillment of this healthcare supply. This delivery order is tied to a larger, long-term definitive contract previously awarded to DMS Pharmaceutical Group, indicating continuity and reliability in pharmaceutical procurement. The award was competitively procured under the existing contract umbrella, and the short timeline for delivery emphasizes prompt service. The contract performance period spans a single day, reflecting the urgent and specific nature of this pharmaceutical requirement.
Description
4571128595!NUCALA 100 MG/ML AUTO-INJECTORML